| scholarly article | Q13442814 |
| P356 | DOI | 10.1086/323081 |
| P8608 | Fatcat ID | release_fixqpoivj5cfvpyjrty7gndhbe |
| P698 | PubMed publication ID | 11517428 |
| P5875 | ResearchGate publication ID | 11829050 |
| P50 | author | Ann C Duerr | Q90925362 |
| Susan Cu-Uvin | Q96186413 | ||
| Jacquie Astemborski | Q106588605 | ||
| P2093 | author name string | Daniel R | |
| Shah K | |||
| Ahdieh L | |||
| Burk R | |||
| Klein RS | |||
| Safaeian M | |||
| Schuman P | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | viral persistence | Q44134905 |
| P304 | page(s) | 682-690 | |
| P577 | publication date | 2001-08-24 | |
| P1433 | published in | Journal of Infectious Diseases | Q4051141 |
| P1476 | title | Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women | |
| P478 | volume | 184 |
| Q38780225 | A Comparison of the Natural History of HPV Infection and Cervical Abnormalities among HIV-Positive and HIV-Negative Women in Senegal, Africa |
| Q59336574 | A prospective cohort study to evaluate immunosuppressive cytokines as predictors of viral persistence and progression to pre-malignant lesion in the cervix in women infected with HR-HPV: study protocol |
| Q89970071 | Age, absolute CD4 count, and CD4 percentage in relation to HPV infection and the stage of cervical disease in HIV-1-positive women |
| Q28385325 | Anal human papillomavirus (HPV) prevalences and factors associated with abnormal anal cytology in HIV-infected women in an urban cohort from Rio de Janeiro, Brazil |
| Q92992913 | Assessing the cost-effectiveness of HPV vaccination strategies for adolescent girls and boys in the UK |
| Q36405118 | Association of HIV viral load and CD4 cell count with human papillomavirus detection and clearance in HIV-infected women initiating highly active antiretroviral therapy |
| Q38873796 | Association of Risk of Viremia, Immunosuppression, Serious Clinical Events, and Mortality With Increasing Age in Perinatally Human Immunodeficiency Virus-Infected Youth |
| Q47225608 | Association of antiretroviral therapy with high-risk human papillomavirus, cervical intraepithelial neoplasia, and invasive cervical cancer in women living with HIV: a systematic review and meta-analysis |
| Q37092790 | Associations between sexually transmitted infections, high-risk human papillomavirus infection, and abnormal cervical Pap smear results in OB/GYN outpatients. |
| Q36319807 | Associations of Human Papillomavirus (HPV) genotypes with high-grade cervical neoplasia (CIN2+) in a cohort of women living with HIV in Burkina Faso and South Africa |
| Q36467682 | Biology of HPV in HIV infection |
| Q36571067 | Bonafide, type-specific human papillomavirus persistence among HIV-positive pregnant women: predictive value for cytological abnormalities, a longitudinal cohort study |
| Q35694739 | CD4+ cell count and HIV load as predictors of size of anal warts over time in HIV-infected women. |
| Q88336925 | CHAPTER 5 HPV infection and HPV-associated neoplasia in immunocompromised women |
| Q37515370 | Cancer risk in HIV-infected persons: influence of CD4(+) count |
| Q36421345 | Cervical HPV natural history among young Western Cape, South African women: The randomized control EVRI Trial |
| Q37098251 | Cervical and anal HPV infection: cytological and histological abnormalities in HIV-infected women in Thailand |
| Q34773250 | Cervical cancer risk factors among HIV-infected Nigerian women |
| Q64062675 | Cervical cancer screening among women living with HIV: a cross-sectional study using the baseline questionnaire data from the Canadian HIV Women's Sexual and Reproductive Health Cohort Study (CHIWOS) |
| Q35592340 | Cervical cancer screening and treatment of cervical intraepithelial neoplasia in female sex workers using "screen and treat" approach. |
| Q40536429 | Cervical cytological abnormalities and human papilloma virus infection in women infected with HIV in Southern India |
| Q34354553 | Cervical human papillomavirus infection among young women engaged in sex work in Phnom Penh, Cambodia: prevalence, genotypes, risk factors and association with HIV infection. |
| Q35174169 | Cervical neoplasia and the HIV-infected patient. |
| Q35252587 | Cervico-vaginal tissue ex vivo as a model to study early events in HIV-1 infection |
| Q37855691 | Cervicovaginal cytological abnormalities in patients with human immunodeficiency virus infection, in relation to disease stage, CD4 cell count and viral load |
| Q44325641 | Characteristics of HPV infection over time in European women who are HIV-1 positive |
| Q47590540 | Comparing Visual Inspection with Acetic Acid to Cytology in Detection of Precancerous Lesions of the Cervix in HIV-Infected Cambodian Women |
| Q35636647 | Comparison of Abnormal Cervical Cytology from HIV Positive Women, Female Sex Workers and General Population |
| Q37336227 | Comparison of careHPV and hybrid capture 2 assays for detection of high-risk human Papillomavirus DNA in cervical samples from HIV-1-infected African women |
| Q35865134 | Cost-effectiveness analysis of human papillomavirus vaccination in South Africa accounting for human immunodeficiency virus prevalence |
| Q24538854 | Could human papillomaviruses be spread through blood? |
| Q34780148 | Current treatment options for management of anal intraepithelial neoplasia |
| Q41021976 | Detection of Human Papilloma Virus (Type 16) among HIV-Positive Women in Ogbomoso, South-Western Nigeria |
| Q35172338 | Determinants of incidence and clearance of high-risk human papillomavirus infections in rural Rakai, Uganda |
| Q33925189 | Determinants of newly detected human papillomavirus infection in HIV-infected and HIV-uninfected injection drug using women |
| Q40238624 | Diagnostic Value of the CareTM HPV Test in Screening for Cervical Intraepithelial Neoplasia Grade 2 or Worse |
| Q35085871 | Discrete-time semi-Markov modeling of human papillomavirus persistence |
| Q48395832 | Distress, sleep difficulty, and fatigue in women co-infected with HIV and HPV. |
| Q42538517 | Does HIV/AIDS have a biological impact on the risk of human papillomavirus-related cancers? |
| Q39993362 | Effect of HIV viral load, CD4 cell count and antiretroviral therapy on human papillomavirus prevalence in urine samples of HIV-infected men. |
| Q45189137 | Effects of imiquimod on latent human papillomavirus anal infection in HIV-infected patients |
| Q36946246 | Effects of smoking on non-AIDS-related morbidity in HIV-infected patients |
| Q35787542 | Evaluation of Cervical Cancer Screening Programs in Côte d'Ivoire, Guyana, and Tanzania: Effect of HIV Status |
| Q36558193 | Evidence for Placental HPV Infection in Both HIV Positive and Negative Women |
| Q55416595 | Evidence of synergistic relationships between HIV and Human Papillomavirus (HPV): systematic reviews and meta-analyses of longitudinal studies of HPV acquisition and clearance by HIV status, and of HIV acquisition by HPV status. |
| Q34149651 | Factors affecting transmission of mucosal human papillomavirus |
| Q34576482 | Frequent detection of HPV before and after initiation of antiretroviral therapy among HIV/HSV-2 co-infected women in Uganda |
| Q34212799 | Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the |
| Q35627563 | Gynecologic issues in the HIV-infected woman |
| Q42140279 | Gynecologic issues in the HIV-infected woman |
| Q30815896 | HIV and pre-neoplastic and neoplastic lesions of the cervix in South Africa: a case-control study. |
| Q47548955 | HIV-positive women have higher risk of HPV infection, precancerous lesions, and cervical cancer: a systematic review and meta-analysis |
| Q35623688 | HPV Infection in a Cohort of HIV-Positive Men and Women: Prevalence of Oncogenic Genotypes and Predictors of Mucosal Damage at Genital and Oral Sites |
| Q28652424 | HPV clearance and the neglected role of stochasticity |
| Q34448633 | HPV clearance in postpartum period of HIV-positive and negative women: a prospective follow-up study. |
| Q58281383 | HPV in sub-Saharan Africa |
| Q36606596 | HPV type infection in different anogenital sites among HIV-positive Brazilian women |
| Q46355059 | HPV vaccination of immunocompromised hosts |
| Q90035185 | HPV-FRAME: A consensus statement and quality framework for modelled evaluations of HPV-related cancer control |
| Q34231736 | High prevalence of human papillomavirus infections in urine samples from human immunodeficiency virus-infected men. |
| Q37443038 | High rates of incident and prevalent anal human papillomavirus infection among young men who have sex with men. |
| Q43585122 | High-grade histologic lesions in women with low-grade squamous intraepithelial lesion cytology from a region of Thailand with a high incidence of cervical cancer |
| Q37509723 | High-risk cervical human papillomavirus infections among human immunodeficiency virus-positive women in the Bahamas |
| Q46965101 | High-risk human papillomavirus among HIV-infected women with normal cervical cytology: a pilot study in Jos, Nigeria |
| Q35186321 | High-risk human papillomavirus in HIV-infected women undergoing cervical cancer screening in Lilongwe, Malawi: a pilot study |
| Q36614735 | High-risk human papillomavirus infection in HIV-positive African women living in Europe |
| Q39229942 | High-risk human papillomavirus types in HIV-infected and HIV-uninfected young women in KwaZulu-Natal, South Africa: implications for vaccination |
| Q45611409 | Highly active antiretroviral therapy and cervical squamous intraepithelial lesions in human immunodeficiency virus-positive women |
| Q33574329 | Human Immunodeficiency Virus and Human Papilloma Virus - why HPV-induced lesions do not spontaneously resolve and why therapeutic vaccination can be successful |
| Q37441134 | Human Papillomavirus (HPV) type 16 and type 18 DNA Loads at Baseline and Persistence of Type-Specific Infection during a 2-year follow-up |
| Q53697945 | Human papilloma virus correlates of high grade cervical dysplasia in HIV-infected women in Mombasa, Kenya: a cross-sectional analysis. |
| Q33794306 | Human papillomavirus detection in women with and without human immunodeficiency virus infection in Colombia |
| Q36612102 | Human papillomavirus genotype distribution and cervical squamous intraepithelial lesions among high-risk women with and without HIV-1 infection in Burkina Faso |
| Q46806693 | Human papillomavirus genotypes and phylogenetic analysis of HPV-16 variants in HIV-1 infected subjects in Italy |
| Q42244723 | Human papillomavirus infection among human immunodeficiency virus-infected women in Maharashtra, India |
| Q38873428 | Human papillomavirus prevalence and cytopathology correlation in young Ugandan women using a low-cost liquid-based Pap preparation. |
| Q38674920 | Human papillomavirus prevalence and genotype distribution among young women and men in Maputo city, Mozambique |
| Q45722582 | Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women. |
| Q36780952 | Human papillomavirus vaccination in HIV-infected women: need for increased coverage |
| Q36486823 | Humoral, mucosal, and cell-mediated immunity against vaccine and nonvaccine genotypes after administration of quadrivalent human papillomavirus vaccine to HIV-infected children |
| Q39302977 | Immunisation practices in centres caring for children with perinatally acquired HIV: A call for harmonisation |
| Q38932142 | Impact of immunosuppression and region of birth on risk of cervical intraepithelial neoplasia among migrants living with HIV in Sweden |
| Q37240151 | Incidence of cervical disease associated to HPV in human immunodeficiency infected women under highly active antiretroviral therapy |
| Q34536772 | Incidence, clearance and predictors of human papillomavirus infection in women. |
| Q34743282 | Increases in human papillomavirus detection during early HIV infection among women in Zimbabwe |
| Q36475561 | Integrating reproductive health services into HIV care: strategies for successful implementation in a low-resource HIV clinic in Lilongwe, Malawi |
| Q36788060 | Invasive cervical cancer risk among HIV-infected women: a North American multicohort collaboration prospective study |
| Q81120967 | Management and outcome of cervical intraepithelial neoplasia lesions: a study of matched cases according to HIV status |
| Q64983267 | Model-estimated effectiveness of single dose 9-valent HPV vaccination for HIV-positive and HIV-negative females in South Africa. |
| Q37566009 | Multiple HPV infections in female sex workers in Western Kenya: implications for prophylactic vaccines within this sub population. |
| Q45477958 | Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women. |
| Q36981226 | Nelfinavir is effective against human cervical cancer cells in vivo: a potential treatment modality in resource-limited settings |
| Q35026841 | Oncogenic human papillomavirus DNA loads in human immunodeficiency virus-positive women with high-grade cervical lesions are strongly elevated |
| Q34983370 | Oral Sex and HPV: Population Based Indications |
| Q47865627 | Palifermin, a recombinant human keratinocyte growth factor, triggers reactivation of anogenital human papillomavirus infection in a HIV-positive patient with diffuse large cell B-cell non-Hodgkin lymphoma |
| Q37001336 | Patterns of persistent genital human papillomavirus infection among women worldwide: a literature review and meta-analysis |
| Q92786639 | Persistence of cervical high-risk human papillomavirus in women living with HIV in Denmark - the SHADE |
| Q45942823 | Persistence of type-specific human papillomavirus infection among Daqing City women in China with normal cytology: a pilot prospective study. |
| Q33883532 | Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis |
| Q45189392 | Polymorphism of human papillomavirus type 31 isolates infecting the genital tract of HIV-seropositive and HIV-seronegative women at risk for HIV infection |
| Q35719648 | Prevalence and incidence of cervical intra-epithelial neoplasia among female sex workers in Korogocho, Kenya. |
| Q37342414 | Prevalence and persistence of cervical human papillomavirus infection in HIV-positive women initiating highly active antiretroviral therapy |
| Q33760807 | Prevalence and predictors of high-risk human papillomavirus infection in a population-based sample of women in rural Uganda |
| Q47141407 | Prevalence of oncogenic human papillomavirus genotypes in patients diagnosed with anogenital malignancies in Botswana |
| Q45812304 | Proceedings From the First Asia-Oceania Research Organisation on Genital Infections and Neoplasia (AOGIN) Meeting |
| Q57297788 | Quadrivalent HPV vaccine in HIV-1-infected early adolescent girls and boys in Kenya: Month 7 and 12 post vaccine immunogenicity and correlation with immune status |
| Q37219765 | Rapid acquisition of HPV around the time of sexual debut in adolescent girls in Tanzania |
| Q91922895 | Rapid immunodiagnostics of multiple viral infections in an acoustic microstreaming device with serum and saliva samples |
| Q34764388 | Rapid rise in detection of human papillomavirus (HPV) infection soon after incident HIV infection among South African women |
| Q40348516 | Rates and determinants of incidence and clearance of cervical HPV genotypes among HIV-seropositive women in Pune, India. |
| Q33619797 | Reduced acquisition and reactivation of human papillomavirus infections among older women treated with cryotherapy: results from a randomized trial in South Africa |
| Q43412275 | Repetitive and consistent cervicovaginal exposure to certain viral pathogens appears to protect against their sexual acquisition in some women: potential mechanisms |
| Q58850470 | Risk estimates for persistent high-risk human papillomavirus infections as surrogate endpoints of progressive cervical disease critically depend on reference category: analysis of the combined prospective cohort of the New Independent States of the F |
| Q34882577 | Risk factors for acquisition and clearance of oral human papillomavirus infection among HIV-infected and HIV-uninfected adults |
| Q35758895 | Risk factors for oral HPV infection among a high prevalence population of HIV-positive and at-risk HIV-negative adults |
| Q34601418 | Serological detection of human papillomavirus type 16 infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women |
| Q39578453 | Sexually Transmitted Infections in Youth With Controlled and Uncontrolled Human Immunodeficiency Virus Infection |
| Q34173407 | Smoking habit, immune suppression, oral contraceptive use, and hormone replacement therapy use and cervical carcinogenesis: a review of the literature |
| Q39144897 | Sustained viral suppression and higher CD4+ T-cell count reduces the risk of persistent cervical high-risk human papillomavirus infection in HIV-positive women |
| Q33290996 | The distribution of sexually-transmitted Human Papillomaviruses in HIV positive and negative patients in Zambia, Africa |
| Q36365671 | The epidemiology of genital human papillomavirus infection |
| Q34089666 | The epidemiology of human papillomavirus infection in HIV-positive and HIV-negative high-risk women in Kigali, Rwanda. |
| Q33718690 | The impact of highly active antiretroviral therapy on prevalence and incidence of cervical human papillomavirus infections in HIV-positive adolescents |
| Q36691070 | The natural history of cervical HPV infection: unresolved issues |
| Q36572919 | The relationship between cocaine use and human papillomavirus infections in HIV-seropositive and HIV-seronegative women |
| Q35542406 | The role of co-infections in mother-to-child transmission of HIV. |
| Q34146342 | Transitional probability-based model for HPV clearance in HIV-1-positive adolescent females |
| Q44576798 | Type-specific duration of human papillomavirus infection: implications for human papillomavirus screening and vaccination |
| Q33863369 | Type-specific incidence, clearance and predictors of cervical human papillomavirus infections (HPV) among young women: a prospective study in Uganda |
| Q40425908 | Usual vulval intraepithelial neoplasia in HIV-positive women - a case series |
| Q58006066 | What Drives the Number of High-Risk Human Papillomavirus Types in the Anal Canal in HIV-Positive Men Who Have Sex With Men? |
Search more.